On the other hand, surprisingly, there was no statistically significant difference in survival rate between IL-36βhigh and IL-36βlow production groups in CRC patients, suggesting that IL-36β may not be a good marker for predicting prognosis of CRC. The gene discussed is IL36B; the disease is colorectal carcinoma.